Q2 2023 Holdings
Filed 2023-08-14 | 12 holdings | $178.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Replimune Group(REPL) | Common Stock | 76029N106 | $69.7M | 3,001,319 | 39.0% |
| Nuvation Bio(NUVB) | Common Stock Class A | 67080N101 | $27.1M | 15,072,340 | 15.2% |
| Alpine Immune Sciences(NVLSEUR) | Common Stock | 02083G100 | $20.9M | 2,029,580 | 11.7% |
| Morphic Holding | Common Stock | 61775R105 | $17.8M | 309,846 | 10.0% |
| Ikena Oncology | Common Stock | 45175G108 | $14.8M | 2,249,123 | 8.3% |
| Theseus Pharmaceuticals | Common Stock | 88369M101 | $6.6M | 711,479 | 3.7% |
| Kronos Bio(KRON1USD) | Common Stock | 50107A104 | $6.6M | 3,818,283 | 3.7% |
| Sana Biotechnology, Inc.(SANA) | Common Stock | 799566104 | $5.0M | 843,750 | 2.8% |
| Spruce Biosciences | Common Stock | 85209E109 | $4.6M | 2,161,022 | 2.6% |
| Immunic Inc(IMUX) | Common Stock | 4525EP101 | $4.5M | 1,788,160 | 2.5% |
| Syros Pharmaceuticals(SYRS) | Common Stock | 87184Q206 | $791.5K | 251,270 | 0.4% |
| Senti Biosciences, Inc. | Common Stock | 81726A100 | $122.8K | 195,792 | 0.1% |